Mani, Inc. (7730.T)

1,221.50

+9.00

+(0.74%)

At close: 3:30:00 PM GMT+9

April CPI, On Holding earnings, NFIB optimism: What to Watch

Market Domination Overtime co-hosts Julie Hyman and Josh Lipton preview several of the top market and industry stories to come tomorrow, Tuesday, May 13, including earnings from companies like JD.com (JD), Tencent Music Entertainment (TME), and Oklo (OKLO), in addition to April's Consumer Price Index (CPI) report due out in the morning. To watch more expert insights and analysis on the latest market action, check out more Market Domination Overtime here.

Yahoo Finance Video 13 hours ago

JD

JDCMF

ONON
Oil prices rise, gold slips, Kindly MD-Nakamoto merger

Yahoo Finance host Josh Lipton tracks today's top moving stocks and biggest market stories in this Market Minute, including rising oil prices (CL=F, BZ=F) after US and Chinese officials agree to terms, gold prices (GC=F) slip, and Kindly MD (KDLY) shares skyrocket on headlines of its merger with Nakamoto to establish a bitcoin (BTC-USD) treasury. Stay up to date on the latest market action, minute-by-minute, with Yahoo Finance's Market Minute.

Yahoo Finance Video 19 hours ago

KDLY

KDLYW

BZ=F
Target, Astera Labs, Kindly MD: Trending Tickers

Wealth host Brad Smith outlines some of today's trending stories. Target (TGT) was downgraded to Underperform from Market Perform by Bernstein analysts, citing the retailer's "difficult trade-off" between sales and margins. Astera Labs (ALAB) was upgraded to Overweight by Morgan Stanley, saying the stock's recent decline is a good entry point. Kindly MD (KDLY) stock skyrockets after announcing a merger with Nakamoto Holdings. To watch more expert insights and analysis on the latest market action, check out more Wealth here.

Yahoo Finance Video 20 hours ago

TGT

ALAB

KDLY
Is SoundHound AI, Inc. (SOUN) the Best AI Stock to Buy Under $10?

We recently published a list of 13 Best AI Stocks to Buy Under $10. In this article, we are going to take a look at where SoundHound AI, Inc. (NASDAQ:SOUN) stands against other best AI stocks to buy under $10. Fears of an artificial intelligence bubble bursting appear overblown. That’s the sentiment echoed on Wall […]

Insider Monkey 10 minutes ago

SOUNW
Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Key Inflation Data

The broad market exchange-traded fund SPDR S&P 500 ETF Trust (SPY) was down 0.1% and the actively tr

PREMIUM
MT Newswires 31 minutes ago

SPY

HMC
JD Earnings Beat Estimates As China E-Commerce Giant's Sales Growth Accelerates For 4th Straight Quarter

Chinese e-commerce giant JD.com reported first quarter results early Tuesday that easily topped estimates for earnings and sales. U.S.-listed JD stock pushed higher in premarket trading after initially dipping negative following the report. JD reported adjusted earnings of 8.41 yuan per share on sales of 301.1 billion yuan, or $41.8 billion, for the March-ended quarter.

Investor's Business Daily 40 minutes ago

JD

JDCMF
Honda Braces for a $4.4 Billion Tariff Bill

Reporting results Tuesday, Honda forecast a roughly two-thirds slide in operating profit for the year through March 2026, due to tariffs and a stronger yen. Chief Executive Officer Toshihiro Mibe said the guidance represented a worst-case scenario. Honda will partly offset the tariff hit by cutting costs and shifting some carmaking to the U.S., including production of the five-door Civic hybrid and some CR-V sports-utility vehicles.

The Wall Street Journal 46 minutes ago

HMC

HNDAF
Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

Topline data expected by year endHead-to-head studies of AL001 versus a marketed lithium carbonate product will be conducted for comparisons of lithium blood and brain/brain-structure pharmacokinetics in healthy subjects ATLANTA, May 13, 2025 (GLOBE NEWSWIRE) -- Alzamend Neuro, Inc. (Nasdaq: ALZN) (“Alzamend”), a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer’s disease (“Alzheimer’s”), bipolar disorder (“BD”), major depressive disorde

GlobeNewswire 46 minutes ago

ALZN
MicroAlgo Inc. Develops Blockchain-Based Traceable IP Rights Protection Algorithm

shenzhen, May 13, 2025 (GLOBE NEWSWIRE) -- MicroAlgo Inc. Develops Blockchain-Based Traceable IP Rights Protection Algorithm Shenzhen, May. 13, 2025/––MicroAlgo Inc. (the "Company" or "MicroAlgo") (NASDAQ: MLGO), today announced the development of a blockchain-based traceable IP rights protection algorithm, aiming to fundamentally address the shortcomings of existing copyright protection technologies and safeguard intellectual property rights.MicroAlgo leverages blockchain's distributed ledger a

GlobeNewswire 46 minutes ago

MLGO

VENAF
Under Armour Continues to Struggle, But Makes Progress on Restructuring Plan

The Baltimore-based sports brand instituted a plan to cut promotions and improve efficiencies one year ago.

WWD 1 hour ago

UAA
On Holding Stock Jumps On Q1 Beat, Lifted Sales Outlook; Birkenstock On Deck

On Holding stock jumped on Q1 results, lifted sales outlook despite tariff pressure. Birkenstock looms Thursday.

Investor's Business Daily 1 hour ago

ONON

CROX

BIRK
UnitedHealth CEO Is Out, Sending Shares Lower

Stephen Hemsley will return to running the healthcare giant he helped build, succeeding CEO Andrew Witty.

The Wall Street Journal 1 hour ago

UNH
UnitedHealth CEO steps down for ‘personal reasons’

UnitedHealth Group CEO Andrew Witty is stepping down immediately from his role for “personal reasons,” the company announced Tuesday.

CNN Business 1 hour ago

UNH
3 Companies Estimated To Be Trading Below Intrinsic Value

The United States market has shown robust performance, with a 3.9% increase over the last week and a 12% rise in the past year, while earnings are projected to grow by 14% annually. In such an environment, identifying stocks that are estimated to be trading below their intrinsic value can offer potential opportunities for investors seeking to capitalize on undervalued assets.

Simply Wall St. 1 hour ago

FSLR

OKTA

IP
Energy Transition Update - Surging Energy Storage Market: Investment Trends and Challenges

According to Coherent Market Insights, the global energy storage system market is poised for substantial growth, driven by a burgeoning focus on renewable energy adoption and the necessity to manage the intermittent generation of solar and wind power. The market, valued at USD 52.95 billion in 2025, is projected to reach USD 86.76 billion by 2032, growing at a CAGR of 7.3%. Key trends influencing this expansion include significant investments in regions like Asia Pacific, technological...

Simply Wall St. 1 hour ago

FSLR

TSLA

AMAT
Coinbase Jumps As Crypto Exchange To Join S&P 500, Replacing Discover Financial

Cryptocurrency exchange Coinbase will replace Discover Financial, which is being acquired by Capital One, before the open on May 19.

Investor's Business Daily 1 hour ago

COIN

COF

COF-PK
CyberArk Software's Q1 Non-GAAP Net Income, Revenue Rise; Full-Year Guidance Revised

CyberArk Software (CYBR) reported Q1 non-GAAP net income Tuesday of $0.98 per diluted share, up from

PREMIUM
MT Newswires 1 hour ago

CYBR
Sea Stock Soars Out Of Base On Earnings. Q1 Sales Grow 30% But Slightly Miss.

Sea stock jumped early Tuesday on an earnings beat for the Southeast Asia internet services company.

Investor's Business Daily 1 hour ago

SE
EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants

Alzamend Neuro, Inc. (NASDAQ:ALZN) on Tuesday announced the initiation of the first of five Phase 2 clinical studies of AL001, with the first study in healthy human subjects. This study follows the development of a novel head coil by Tesla Dynamic Coils BV, a key component of the clinical trial. In collaboration with Massachusetts General Hospital as its clinical trial site, Alzamend aims to explore AL001 and its potential to deliver lithium more effectively in the brain than marketed lithium sa

Benzinga 1 hour ago

ALZN
PDS Health Expands CyberArk Deployment to Automate Certificate Lifecycle Management at Scale

NEWTON, Mass. & PETACH TIKVA, Israel, May 13, 2025--CyberArk (NASDAQ: CYBR), the global leader in identity security, today announced that PDS Health, a leading integrated healthcare support organization serving more than 1,000 dental and primary care practices across the U.S., will extend its CyberArk implementation with additional machine identity security solutions. By adding CyberArk Zero Touch PKI and CyberArk Certificate Manager to its identity security program, PDS Health will modernize it

Business Wire 1 hour ago

CYBR

Performance Overview

Return	7730.T	Nikkei 225 (^N225)
YTD	-31.64%	-4.29%
1-Year	-33.96%	+0.01%
3-Year	-9.15%	+44.48%

News

Life

Entertainment

Finance

Sports

New on Yahoo

Yahoo Finance

Breaking

Mani, Inc. (7730.T)

Related News

April CPI, On Holding earnings, NFIB optimism: What to Watch

Oil prices rise, gold slips, Kindly MD-Nakamoto merger

Target, Astera Labs, Kindly MD: Trending Tickers

Is SoundHound AI, Inc. (SOUN) the Best AI Stock to Buy Under $10?

Exchange-Traded Funds, Equity Futures Lower Pre-Bell Tuesday Ahead of Key Inflation Data

JD Earnings Beat Estimates As China E-Commerce Giant's Sales Growth Accelerates For 4th Straight Quarter

Honda Braces for a $4.4 Billion Tariff Bill

Alzamend Neuro Initiates First Phase II Clinical Trial of AL001 “Lithium in Brain” Study Taking Place at Massachusetts General Hospital

MicroAlgo Inc. Develops Blockchain-Based Traceable IP Rights Protection Algorithm

Under Armour Continues to Struggle, But Makes Progress on Restructuring Plan

On Holding Stock Jumps On Q1 Beat, Lifted Sales Outlook; Birkenstock On Deck

UnitedHealth CEO Is Out, Sending Shares Lower

UnitedHealth CEO steps down for ‘personal reasons’

3 Companies Estimated To Be Trading Below Intrinsic Value

Energy Transition Update - Surging Energy Storage Market: Investment Trends and Challenges

Coinbase Jumps As Crypto Exchange To Join S&P 500, Replacing Discover Financial

CyberArk Software's Q1 Non-GAAP Net Income, Revenue Rise; Full-Year Guidance Revised

Sea Stock Soars Out Of Base On Earnings. Q1 Sales Grow 30% But Slightly Miss.

EXCLUSIVE: Alzamend Neuro Initiates First Phase 2 Trial Of Lead Program In Healthy Human Participants

PDS Health Expands CyberArk Deployment to Automate Certificate Lifecycle Management at Scale

Performance Overview